Healthy Growth across all verticals in FY'22 slide image

Healthy Growth across all verticals in FY'22

Domestic Own Brand Finished Formulation Sales (% Growth) % Growth 33% 18% 67% Brands continue to 2 occupy No1 Position Barugs BETA DRUGS LTD. 9 New products launched in FY21-22 Vision to grow at CAGR of 30% NDDS has been 1 launched MDS-O FY 19-20 FY 20-21 FY 21-22 6 Brands achieved top 5 position in respective market
View entire presentation